Genesystem Co., Ltd. (KOSDAQ:363250)
South Korea
· Delayed Price · Currency is KRW
5,500.00
-340.00 (-5.82%)
At close: Apr 28, 2026
Genesystem Ratios and Metrics
Market cap in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
| Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
| Apr '26 Apr 27, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 |
| Market Capitalization | 41,640 | 27,964 | 59,357 | 65,169 | 58,004 |
| Market Cap Growth | -40.73% | -52.89% | -8.92% | 12.35% | - |
| Enterprise Value | 43,707 | 30,673 | 56,608 | - | - |
| Last Close Price | 5500.00 | 4100.00 | 8440.00 | 9330.00 | 8370.00 |
| Forward PE | - | 14.85 | 14.85 | 14.85 | - |
| PS Ratio | 109.19 | 73.33 | 49.15 | 72.65 | 15.88 |
| PB Ratio | 5.37 | 3.61 | 2.71 | 2.12 | 1.65 |
| P/TBV Ratio | 5.77 | 3.88 | 4.79 | 3.28 | 1.69 |
| EV/Sales Ratio | 114.61 | 80.43 | 46.87 | - | - |
| Debt / Equity Ratio | 0.52 | 0.52 | 0.19 | 0.15 | 0.12 |
| Net Debt / Equity Ratio | 0.28 | 0.28 | -0.16 | -0.32 | -0.64 |
| Net Debt / EBITDA Ratio | -0.25 | -0.25 | 0.40 | 1.10 | 3.60 |
| Net Debt / FCF Ratio | -0.31 | -0.31 | 0.47 | 1.21 | 3.37 |
| Asset Turnover | 0.02 | 0.02 | 0.04 | 0.02 | - |
| Inventory Turnover | 2.19 | 2.19 | 1.20 | 0.79 | - |
| Quick Ratio | 0.78 | 0.78 | 3.08 | 5.99 | 13.76 |
| Current Ratio | 1.08 | 1.08 | 3.93 | 8.65 | 15.50 |
| Return on Equity (ROE) | -99.02% | -99.02% | -36.25% | -24.50% | - |
| Return on Assets (ROA) | -27.34% | -27.34% | -18.37% | -14.80% | - |
| Return on Capital Employed (ROCE) | -81.70% | -81.70% | -37.00% | -26.00% | -16.80% |
| Earnings Yield | -28.71% | -42.75% | -15.02% | -12.15% | -15.51% |
| FCF Yield | -17.06% | -25.40% | -12.80% | -12.54% | -11.47% |
| Buyback Yield / Dilution | 0.46% | 0.46% | 1.47% | -0.69% | - |
Source: S&P Capital IQ. Standard template.
Financial Sources.